scholarly article | Q13442814 |
P356 | DOI | 10.1021/BI101318M |
P953 | full work available at URL | https://pubs.acs.org/doi/pdf/10.1021/bi101318m |
P698 | PubMed publication ID | 21077672 |
P5875 | ResearchGate publication ID | 47793038 |
P50 | author | Ruey-Hwang Chou | Q60566680 |
P2093 | author name string | Chin Yu | |
Han-Min Wang | |||
Sepuru K. Mohan | |||
Sriramoju M. Kumar | |||
P2860 | cites work | Cancer Research | Q326097 |
Journal of Magnetic Resonance | Q3186925 | ||
Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. | Q38339080 | ||
The PIP2 binding mode of the C2 domains of rabphilin-3A | Q38528805 | ||
Fibroblast growth factors, proteins with a broad spectrum of biological activities. | Q40395069 | ||
Anti-angiogenic activity of inositol hexaphosphate (IP6). | Q40528072 | ||
Inositol phosphates and cell signaling: new views of InsP5 and InsP6. | Q40853746 | ||
Inositolhexakisphosphate (InsP6): an antagonist of fibroblast growth factor receptor binding and activity | Q41432415 | ||
Isothermal titration calorimetric study of the association of hen egg lysozyme and the anti-lysozyme antibody HyHEL-5. | Q41479629 | ||
Nature of the interaction of growth factors with suramin | Q42816405 | ||
Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues. | Q42823294 | ||
Thermodynamic characterization of the human acidic fibroblast growth factor: evidence for cold denaturation | Q43644768 | ||
Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes | Q44047107 | ||
Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression | Q45150380 | ||
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin | Q47682341 | ||
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation | Q54246457 | ||
β-Trefoil fold | Q56339973 | ||
Three-Dimensional Structure of Acidic Fibroblast Growth Factor in Solution: Effects of Binding to a Heparin Functional Analog | Q58622050 | ||
Three-dimensional structure and thermodynamics of antigen binding by anti-lysozyme antibodies | Q58670761 | ||
PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to C?,C? transfer and C?,Caromatic correlations | Q60173739 | ||
Three-fold structural pattern in the soybean trypsin inhibitor (Kunitz) | Q66994216 | ||
Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin | Q68499278 | ||
Thermodynamics of protein association reactions: forces contributing to stability | Q70820225 | ||
Transplacental carcinogenesis by stilbestrol | Q95784569 | ||
Enhanced-Sensitivity Triple-Resonance Spectroscopy with Minimal H2O Saturation | Q108784215 | ||
A Gradient-Enhanced HCCH-TOCSY Experiment for Recording Side-Chain 1H and 13C Correlations in H2O Samples of Proteins | Q110644268 | ||
Structural basis for FGF receptor dimerization and activation | Q22010544 | ||
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization | Q24290400 | ||
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate | Q27640887 | ||
Heparin structure and interactions with basic fibroblast growth factor | Q27732601 | ||
X-ray crystal structure of human acidic fibroblast growth factor | Q27732790 | ||
Structure of a heparin-linked biologically active dimer of fibroblast growth factor | Q27760195 | ||
Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas | Q27765171 | ||
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information | Q27860814 | ||
Protein backbone angle restraints from searching a database for chemical shift and sequence homology | Q27861108 | ||
Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate | Q28286658 | ||
Angiogenesis in cancer, vascular, rheumatoid and other disease | Q29547165 | ||
HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets | Q29615981 | ||
Angiogenic factors | Q29620582 | ||
Antioxidant functions of phytic acid | Q34206552 | ||
Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic | Q34275641 | ||
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate | Q34442255 | ||
Protection against cancer by dietary IP6 and inositol | Q34574206 | ||
Heat capacity and entropy changes in processes involving proteins | Q35063139 | ||
Applications of calorimetric methods to drug discovery and the study of protein interactions | Q35064543 | ||
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction | Q35229509 | ||
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity | Q35994206 | ||
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity. | Q36639272 | ||
A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients | Q36732974 | ||
The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue. | Q38309317 | ||
Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods. | Q38310289 | ||
Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide | Q38327325 | ||
P433 | issue | 50 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | angiogenesis inhibitor | Q574834 |
P304 | page(s) | 10756-10764 | |
P577 | publication date | 2010-11-23 | |
P1433 | published in | Biochemistry | Q764876 |
P1476 | title | Molecular Level Interaction of the Human Acidic Fibroblast Growth Factor with the Antiangiogenic Agent, Inositol Hexaphosphate, | |
P478 | volume | 49 |